Medium-chain triglyceride supplementation and the association with growth, nutritional status and clinical outcomes in infants with biliary atresia
This is the first study to investigate the association of MCT with growth, nutritional status and clinical outcomes in biliary atresia. No association was found between MCT with growth beyond 3-months, overall nutritional status or clinical outcomes. The association between MCT (g/kg/d) and poorer growth in the first 3-months may be explained by infants with poorer growth drinking more or being prescribed more MCT formula milk. A randomised controlled trial could help to better understand this association.
Authors
- Anil Kumar Dhawan (ORCID: https://orcid.org/0000-0002-4942-0845)
- Kevin Whelan (ORCID: https://orcid.org/0000-0001-5414-2950)
- Salma A. Ayis (ORCID: https://orcid.org/0000-0002-0449-869X)
- Sara Mancell (ORCID: https://orcid.org/0000-0002-6811-3461)
- Gillian Geaney
Institutions
- King's College London (GB)
- King's College Hospital NHS Foundation Trust (GB)
Publication Details
- Journal
- Clinical Nutrition
- Published
- 2024-12-03
- DOI
- https://doi.org/10.1016/j.clnu.2024.11.028
- Citations
- 3
- Primary Topic
- Pediatric Hepatobiliary Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.72
Funders
- National Institute for Health and Care Research